Core Scientific
(NASDAQ) CORZ
Core Scientific Financials at a Glance
Market Cap
$7.47BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$354.74M
Net Income (TTM)
-$1.22B
EPS (TTM)
-$1.15
P/E Ratio
-20.48
Dividend
$0.00
Beta (Volatility)
2.44 (High)
Dividend
$0.00
Beta (Volatility)
2.44 (High)
Price
$23.49
Volume
361,991
Open
$23.59
Price
$23.49
Volume
361,991
Open
$23.59
Previous Close
$23.49
Daily Range
$22.92 - $24.19
52-Week Range
$12.60 - $30.46
Estimated Earnings Date
Aug 14, 2026
Dividend
$0.00
Beta (Volatility)
2.44 (High)
Price
$23.49
Volume
361,991
Open
$23.59
Previous Close
$23.49
Daily Range
$22.92 - $24.19
52-Week Range
$12.60 - $30.46
Estimated Earnings Date
Aug 14, 2026
CORZ News
CORZ: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Core Scientific
Industry
Software
Sector
Information TechnologyEmployees
325
CEO
Adam Sullivan
Website
corescientific.comHeadquarters
Dover, DE 78704, US
CORZ Financials
Key Financial Metrics (TTM)
Gross Margin
16.75%
Operating Margin
-28.89%
Net Income Margin
-342.93%
Return on Equity
109.08%
Return on Capital
-230.11%
Return on Assets
-39.63%
Earnings Yield
-4.88%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$7.47BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
317.88M
Volume
361.99K
Avg. Volume
14.14M
Financials (TTM)
Gross Profit
$59.43M
Operating Income
-$102.47M
EBITDA
-$229.00M
Operating Cash Flow
$568.73M
Capital Expenditure
-$1.04B
Free Cash Flow
-$471.20M
Cash & ST Invst.
$1.01B
Total Debt
$2.06B
Core Scientific Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$115.24M
+44.9%
Gross Profit
$29.75M
+262.2%
Gross Margin
25.81%
N/A
Market Cap
$7.47BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$22.98M
N/A
Employees
325
N/A
Net Income
-$347.19M
-160.2%
EBITDA
-$321.91M
-153.8%
Quarterly Fundamentals
Total Cash
$1.01B
+44.0%
Total Debt
$2.06B
+72.1%
Accounts Receivable
$315.67M
+30908.5%
Inventory
$0.00
N/A
Long Term Debt
$1.06B
-9.0%
Short Term Debt
$993.94M
+3533.2%
Return on Assets
-39.63%
N/A
Return on Invested Capital
-25.13%
N/A
Free Cash Flow
-$139.35M
-8.0%
Operating Cash Flow
$249.88M
+654.8%